These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2124220)

  • 41. Private practice evaluation of the safety and efficacy of bupropion in depressed outpatients.
    Kirksey DF; Harto-Truax N
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):143-7. PubMed ID: 6406446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bupropion: a new clinical profile in the psychobiology of depression.
    Shopsin B
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):140-2. PubMed ID: 6406445
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of propofol and methohexitone in anaesthesia for ECT: effect on seizure duration and outcome.
    Kirkby KC; Beckett WG; Matters RM; King TE
    Aust N Z J Psychiatry; 1995 Jun; 29(2):299-303. PubMed ID: 7487795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ECT seizure duration and efficacy.
    Daniel WF
    Br J Psychiatry; 1995 Mar; 166(3):399-401. PubMed ID: 7788137
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical profile of the novel antidepressant bupropion.
    Stern WC; Harto-Truax N; Rogers J; Miller L
    Adv Biochem Psychopharmacol; 1982; 32():21-34. PubMed ID: 6807060
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment choice after one antidepressant fails: a survey of northeastern psychiatrists.
    Nierenberg AA
    J Clin Psychiatry; 1991 Sep; 52(9):383-5. PubMed ID: 1910035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EEG monitoring of ECT.
    Jones EM
    Br J Psychiatry; 1989 Jun; 154():880-1. PubMed ID: 2597899
    [No Abstract]   [Full Text] [Related]  

  • 48. Theophylline reversal of electroconvulsive therapy (ECT) seizure inhibition.
    Swartz CM; Lewis RK
    Psychosomatics; 1991; 32(1):47-51. PubMed ID: 2003137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the safety and efficacy of bupropion in depression.
    Halaris AE; Stern WC; Van Wyck Fleet J; Reno RM
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):101-3. PubMed ID: 6406435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Would monitoring by electroencephalogram improve the practice of electroconvulsive therapy?
    Scott AI; Shering PA; Dykes S
    Br J Psychiatry; 1989 Jun; 154():853-7. PubMed ID: 2597893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular effects of bupropion in depressed patients with heart disease.
    Roose SP; Dalack GW; Glassman AH; Woodring S; Walsh BT; Giardina EG
    Am J Psychiatry; 1991 Apr; 148(4):512-6. PubMed ID: 1900980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is there a delay in the onset of the antidepressant effect of electroconvulsive therapy?
    Rodger CR; Scott AI; Whalley LJ
    Br J Psychiatry; 1994 Jan; 164(1):106-9. PubMed ID: 8137089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Naloxone and ECT seizure length.
    Rasmussen KG; Jarvis MR; Zorumski CF
    Convuls Ther; 1997 Mar; 13(1):44-6. PubMed ID: 9152589
    [No Abstract]   [Full Text] [Related]  

  • 54. Therapeutic drug monitoring of bupropion.
    Preskorn SH; Fleck RJ; Schroeder DH
    Am J Psychiatry; 1990 Dec; 147(12):1690-1. PubMed ID: 2123082
    [No Abstract]   [Full Text] [Related]  

  • 55. Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure.
    Roose SP; Glassman AH; Giardina EG; Johnson LL; Walsh BT; Bigger JT
    J Clin Psychopharmacol; 1987 Aug; 7(4):247-51. PubMed ID: 3114333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tricyclic-induced electroencephalogram abnormalities and plasma drug concentrations.
    Preskorn SH; Othmer SC; Lai CW; Othmer E
    J Clin Psychopharmacol; 1984 Oct; 4(5):262-4. PubMed ID: 6436340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The current status of seizure duration in the practice of electroconvulsive therapy.
    Lalla FR; Milroy T
    Can J Psychiatry; 1996 Jun; 41(5):299-304. PubMed ID: 8793149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lithium for post-electroconvulsive therapy depressive relapse prevention: a consideration of the evidence.
    Rasmussen KG
    J ECT; 2015 Jun; 31(2):87-90. PubMed ID: 25551481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controlled trials of electroconvulsive therapy.
    Crow TJ; Johnstone EC
    Ann N Y Acad Sci; 1986; 462():12-29. PubMed ID: 2871792
    [No Abstract]   [Full Text] [Related]  

  • 60. Depressive disorders.
    Geddes J; Butler R
    Clin Evid; 2002 Dec; (8):951-73. PubMed ID: 12603922
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.